Who owns Sensei Biotherapeutics Inc?
- Ticker: SNSE
- CUSIP Number: 81728a207
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold Sensei Biotherapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 722k | $23M | 100% | Mar 2026 |
|
| Cormorant Asset Management | 306k | $9.7M | 100% | Mar 2026 |
|
| Millennium Management | 147k | $4.6M | 100% | Mar 2026 |
|
| Franklin Resources | 134k | $4.2M | 100% | Mar 2026 |
|
| Stempoint Capital | 133k | $4.2M | 100% | Mar 2026 |
|
| Trails Edge Capital Partners | 125k | $3.9M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 62k | $1.9M | 100% | Mar 2026 |
|
| Hrt Financial | 58k | $1.8M | 100% | Mar 2026 |
|
| Suvretta Capital Management | 35k | $1.1M | 100% | Mar 2026 |
|
| Bank of America Corporation | 33k | $1.0M | 100% | Mar 2026 |
|
| Logos Global Management | 30k | $946k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 26k | $823k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 20k | $641k | 100% | Mar 2026 |
|
| Fred Alger Management | 18k | $578k | 100% | Mar 2026 |
|
| Balyasny Asset Management | 16k | $511k | 100% | Mar 2026 |
|
| Catalio Capital Management | 15k | $464k | 0% | Mar 2026 |
|
| Renaissance Technologies | 12k | $123k | 11% | Dec 2025 |
|
| Geode Capital Management | 9.5k | $300k | 100% | Mar 2026 |
|
| Jane Street | 8.9k | $280k | 100% | Mar 2026 |
|
| Morgan Stanley | 8.8k | $277k | 87850% | Mar 2026 |
|
| Vanguard Capital Management | 7.8k | $244k | 100% | Mar 2026 |
|
| Ikarian Capital | 6.4k | $200k | -70% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 6.3k | $199k | 100% | Mar 2026 |
|
| UBS Group | 4.5k | $143k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 9.00 | $284.000400 | 0% | Mar 2026 |
|
| SBI Securities | 4.00 | $126.000000 | 0% | Mar 2026 |
|
Who sold out of Sensei Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 32.00 | $302.000000 |
| Bnp Paribas | Dec 2025 | 7.00 | $59.000200 |